*By Christian Smith*
After an overdose earlier this week, Demi Lovato's life was reportedly saved by Narcan, a nasal administrator of naloxone that counteracts the effects of opioids. When administered quicklyーthrough either nasal mist or injectionーnaloxone can temporarily halt an overdose, allowing EMTs enough time to respond. The medication is available without a prescription in 49 states, and the generic version costs about $20 per dose.
But all merits aside, is the drug's accessibility enabling addicts to push their limits?
Dr. Roger Crystal, the lead inventor of Narcan and CEO of Opiant Pharmaceuticals, says there's little evidence to support that concern.
"Addiction like any kind of chronic disease is something you can control using better medication, but ultimately you can't cure," Crystal told Cheddar. "To think about an opioid addict behaving rationally and saying, 'well because I have access to Narcan I'll shoot more heroin, inject more heroin' there's no proof for that whatsoever."
Naloxone is considered some of the best ammunition on the front lines of America's growing opioid epidemic. A reported 2 million Americans have an addition to opioidsーand the number isn't going down. U.S. Surgeon General Jerome Adams [issued an advisory](https://www.surgeongeneral.gov/priorities/opioid-overdose-prevention/naloxone-advisory.html) in April urging anyoneーand their close family and friendsーwho uses painkillers, heroin, fentanyl, or other opioids to carry naloxone in case of an emergency.
Crystal isn't stopping at Narcan: he told Cheddar he's also developing a heroin vaccine, suggesting the inventor has lofty ambitions for the future of overdose prevention.
Although Crystal may be aware of lingering ethical concerns, he doesn't think they dwarf his mission. After all, Lovato has him to thank.
"Putting it in the hands of everyone and anyone is critical," Crystal said.
For more on this story, [click here](https://cheddar.com/videos/how-one-pharmaceutical-company-is-fighting-the-opioid-epidemic).
The decision, announced last week, will impact about 5,600 hotels and 850,000 guest rooms, according to IHG, which operates 17 hotel brands, including Holiday Inn and Crowne Plaza.
Shark Week is back for its 31st year and fans can bite into a new lineup of shows featuring some of the ocean's fiercest predators.
Digital health company Livongo had a successful public debut Thursday on the Nasdaq. It's the latest in a wave of digital health companies entering the public markets. Hemant Taneja, managing director at General Catalyst, joins Cheddar to discuss.
Smart glass, which comes with its own IP address, is being installed in office buildings around the country. Rao Mulpuri, CEO of View, which makes smart glass, joined Cheddar to discuss how his company’s windows can actually improve worker productivity.
ELLO Capital will focus on guiding U.S.-focused cannabis, hemp, and ancillary companies through mergers and acquisitions, capital raises and private placements. The company also aims to assist “traditional cpg companies that are looking at how to navigate the CBD or cannabis world,” like Altria, Diageo, and Constellation.
Everyone who lives long enough is likely to experience back pain. And the cause isn't just aging. We have evolution to blame for a spine that's an engineering nightmare. Cheddar Explores how our spines changed to accommodate human bipedalism.
The modern-day space race just took a major step toward maturity, with Sir Richard Branson's announcement that Virgin Galactic will go public. When it lists later this year, Virgin will become the first publicly traded space-tourism company.
Researchers at the University of Nebraska Medical Center and Temple University reported using gene therapy to eradicate HIV in mice. Now the team is considering how to turn that into a life-saving cure for humans.
The holiday has become prime time for companies slinging CBD products for nervous pets. But with so many products and so little regulation, it can be tough for well-meaning pet owners to know which products are safe and whether they actually work.
Democratic candidates were asked about the climate crisis during the first presidential primary debates on Wednesday and Thursday in Miami, a city that is currently experiencing its hottest week in more than three decades.
